Convergence Investment Partners’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,573
Closed -$420K 193
2023
Q3
$420K Sell
2,573
-134
-5% -$23.6K 0.25% 96
2023
Q2
$496K Buy
2,707
+855
+46% +$123K 0.28% 96
2023
Q1
$247K Buy
+1,852
New +$218K 0.15% 146
2022
Q4
Sell
-2,290
Closed -$139K 206
2022
Q3
$139K Buy
+2,290
New +$148K 0.09% 179
2018
Q1
Sell
-38,800
Closed -$1.11M 1019
2017
Q4
$1.11M Buy
+38,800
New +$1.22M 0.15% 232

Other funds holding ACLS

Convergence Investment Partners's ACLS Position: Q4 2023 in Review

Convergence Investment Partners sold out of Axcelis (ACLS) in Q4 2023, closing a stake of 2,573 shares — an estimated $420K sold.

Convergence Investment Partners first reported a position in ACLS in Q4 2017 and held it in 5 quarters. The position peaked at $1.11M in Q4 2017. 421 funds tracked by Wall St. Rank hold ACLS as of Q4 2023.

  • Convergence Investment Partners reported no remaining Axcelis position as of Q4 2023 after selling out during the quarter.
  • Convergence Investment Partners sold 2,573 Axcelis shares in Q4 2023, an estimated $420K.
  • Convergence Investment Partners first reported a position in Axcelis in Q4 2017 and held it in 5 quarters.
  • Convergence Investment Partners's Axcelis position peaked at $1.11M in Q4 2017.
  • 421 funds tracked by Wall St. Rank held Axcelis as of Q4 2023.

Based on Convergence Investment Partners's 13F filing for Q4 2023, filed 5 Feb 2024.